Carboxylic acid ester prodrug inhibitors of MEK

US10654792B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10654792-B2
Application numberUS-201615383635-A
CountryUS
Kind codeB2
Filing dateDec 19, 2016
Priority dateNov 15, 2012
Publication dateMay 19, 2020
Grant dateMay 19, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention generally relates to compounds having structure I: wherein x represents alkyl, aryl or het-aryl, each of y independently represents hydrogen or halogen and z represents hydrogen or alkyl. Further, said compounds are inhibitors of MEK 1, 2 and 5. Furthermore, the invention includes methods of making said compounds, compositions including said compounds and uses for inhibiting MEK 1, 2 and 5.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a compound of structure Ia or structure Ib: the method comprising a reaction scheme selected from the group consisting of the following: wherein: X 1 is hydrogen, X 2 is hydrogen, alkyl, aryl or hetaryl, Y 1 is halogen, Z is hydrogen or alkyl, and Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen, or Y 4 and Y 5 are hydrogen, and Y 2 and Y 3 are halogen. 2. The method of claim 1 , wherein Y 4 and Y 5 are hydrogen and Y 2 and Y 3 are fluorine. 3. The method of claim 1 , wherein Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen. 4. A method for preparing an inhibitor of mitogen-activated protein kinase 1, 2 and 5, of structure Ia or structure Ib: the method comprising a reaction scheme selected from the group consisting of the following: wherein: X 1 is hydrogen, X 2 is hydrogen, alkyl, aryl or hetaryl, Y 1 is halogen, Z is hydrogen or alkyl, and Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen, or Y 4 and Y 5 are hydrogen, and Y 2 and Y 3 are halogen. 5. The method of claim 4 , wherein Y 4 and Y 5 are hydrogen and Y 2 and Y 3 are fluorine. 6. The method of claim 4 , wherein Y 4 is fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen. 7. The method of claim 4 , wherein Y 1 and Y 4 are fluorine, Y 5 is iodine, and Y 2 and Y 3 are hydrogen.

Assignees

Inventors

Classifications

  • C07C229/58Primary

    having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids · CPC title

  • C07C227/10Primary

    with simultaneously increasing the number of carbon atoms in the carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10654792B2 cover?
The invention generally relates to compounds having structure I: wherein x represents alkyl, aryl or het-aryl, each of y independently represents hydrogen or halogen and z represents hydrogen or alkyl. Further, said compounds are inhibitors of MEK 1, 2 and 5. Furthermore…
Who is the assignee on this patent?
Duquesne Univ Of The Holy Ghost, Univ Holy Ghost Duquesne
What technology area does this patent fall under?
Primary CPC classification C07C229/58. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).